Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche image

Strong growth for Roche in latest results

July 25, 2013
Sales and Marketing Alexion, Q2, Rituxan, Roche

Roche has seen strong sales growth in the past six months as it lines up new products to replace its …

News
Roche image

New Roche leukaemia drug beats rival

July 24, 2013
Research and Development, Sales and Marketing Rituxan, Roche, leukaemia, obinutuzumab

Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …

News
Mabthera image

NICE ‘no’ for MabThera

July 23, 2013
Sales and Marketing MabThera, NHS, NICE, Roche

Roche has been dealt a blow by NICE, with the health watchdog deciding that MabThera should not be used on …

News
Lucentis image

Lucentis and Avastin equal in efficacy

July 19, 2013
Research and Development, Sales and Marketing Lucentis, Novartis, Roche, avastin

Latest results released this morning from a UK government trial show that off-label use of Roche’s Avastin is just as …

News

Roche ‘considers’ Alexion bid

July 16, 2013
Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …

News
Roche image

Roche’s Erivedge gains conditional EU approval

July 15, 2013
Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf

Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …

News
boehringer_german_building_at_night_5

FDA approves Boehringer’s lung cancer drug

July 12, 2013
Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer

Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …

News
Roche image

Blow for Roche as it halts diabetes drug trial

July 10, 2013
Research and Development, Sales and Marketing Roche, aleglitazar, diabetes

Roche has stopped a late-stage trial of its investigational diabetes drug aleglitazar over safety concerns. The move was prompted by …

News

Roche leukaemia drug granted speedy US review

July 3, 2013
Research and Development, Sales and Marketing CLL, FDA, Roche, leukaemia, obinutuzumab

Roche’s investigational leukaemia drug could be available for US patients by the end of the year as the FDA looks …

News
fda image

FDA gives Perjeta priority

July 3, 2013
Sales and Marketing FDA, Perjeta, Roche, breast cancer

The FDA has granted priority review status to an application for Roche’s Perjeta to be used before surgery in HER2-positive …

News
Roche image

Roche buys blood testing firm for $220m

July 2, 2013
Sales and Marketing CMI, Diagnostics, Roche

Roche has acquired Boston-based Constitution Medical Investors in order to buy into its haematology testing system. The cancer drug specialist …

News
Avastin image

Avastin gets GBM approval

June 18, 2013
Research and Development, Sales and Marketing GBM, Roche, avastin

Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …

News
Roche image

Lilly and Roche back US research institute

May 31, 2013
Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …

News
EMA image

Court rules against EMA disclosure

May 2, 2013
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

News

Roche restructures life science business

April 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts

Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025